Archives

How evolving inspection expectations, digital manufacturing, and AI-enabled quality systems are reshaping pharmaceutical control strategies.  For many pharmaceutical organizations, the FDA’s draft guidance on  Considerations  for Complying with 21...

After startup, most facilities slowly return to uncertainty. Procedures evolve, equipment ages, and process behavior drifts. Teams spend increasing effort rediscovering system behavior through deviations...

As global regulations continue to evolve, life sciences organizations face increasing pressure to meet stringent compliance expectations without slowing innovation or compromising product quality. The...

The data life cycle is the framework through which organizations manage data from initial creation to final destruction. In regulated environments, maintaining control over this...

Technology transfer (TT) in biopharmaceutical manufacturing is the structured process of transferring product and process knowledge from a Sending Unit (SU) to a Receiving Unit...

The life sciences sector continues to evolve at a rapid pace, driven by accelerated development timelines, heightened regulatory expectations and increasing pressure to operationalize quality from the earliest stages...

Achieving operational excellence in pharmaceutical manufacturing requires Program Managers who can align communication across multiple departments and disciplines. They serve as a central point of...

The biopharmaceutical industry is evolving rapidly as manufacturers pursue greater speed, quality and reliability. A central driver of this change is the digital twin for...

How digital regulation will reshape quality, compliance and operational expectations across the life sciences ecosystem. Written by: Cassidy Reid & Alice Redmond A Regulator Moving...